Direct Meds vs Embody
Oral semaglutide is $249 at Direct Meds against $229 at Embody, a gap narrow enough that the route each seller actually discounts matters more.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Direct Meds
Partner
$249/mo
$297 a month for injectable semaglutide and $399 for tirzepatide, each stated as billed monthly and covering the visit, supplies and shipping with no membership fee. The per-day figures beside them are the same monthly rate divided by the days in a month.
- Prices published with the billing interval stated beside them
- The figure covers medication, visit, supplies and shipping
- A starting dose schedule is published in milligrams
- The state list is published, all states except Mississippi and Louisiana
- Priced well above the typical figure in this category
- Per-day framing makes a large monthly number look small
- The landing page leads with a $147 first month, not the $297 standing rate
- The dispensing pharmacies are unnamed and described inconsistently
Pick it for: One monthly figure covering the visit, supplies and shipping
Not for: Anyone shopping this market on price.
Embody
Partner
$229/mo
$79 a month for semaglutide is described at checkout as flat forever, and the terms alongside it name a different list price. Tirzepatide is $129. Both are low; both depend on a promotion whose permanence is a claim rather than a rate.
- $79 is at the low end of anything published in this market
- Both molecules in both routes, all four priced
- Bundles published with their monthly equivalents
- Fifty states
- The rate depends on a promotion, not a list price
- The terms name a higher list price than the checkout does
- Buyer complaints allege the “flat forever” lock was not always honored
- The orals cost roughly three times the injections
Pick it for: A slightly lower oral rate, and a far lower one if you take the shot
Not for: Anyone who needs the price to be contractual rather than promotional.
Our verdict
Direct Meds sells its oral as sublingual drops and quotes $249 on a 90-day supply billed monthly, with the visit, supplies and shipping inside the figure; some dosages come in lower. Embody's $229 is a flat monthly rate, but the promotional pricing Embody is known for sits on its $79 injection and does not reach the oral.
What actually separates them
Direct Meds and Embody state different things about published price, names its pharmacy and where you can use it. Everything else they publish, they publish the same way.
Direct Meds costs $20 more than Embody — 9% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $2,748 at Embody against $2,988 at Direct Meds — a difference of $240.
| Direct Meds | Embody | |
|---|---|---|
| Published price | $249/mo | $229/mo |
| Names its pharmacy | No | Yes |
| Where you can use it | US except MS and LA | 50 states |
Before you choose either
Whether these two publish a milligram dose is not settled in our records for both of them, so treat the two prices as not yet comparable and ask each what dose the monthly figure buys. Set the answers against every published price we hold — a lower monthly price at a smaller dose is not the cheaper option.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.